| Registry | NCT04686045 |
|---|---|
| Status | Unknown |
| Study type | Observational |
| Enrollment | 10000 (Estimated) |
| Sponsor | Jan Kochanowski University (Other) |
| Conditions | Atrial Fibrillation; Stroke Prevention |
| Interventions | observational study (Other) |
| Dates | start 2021-01-01, primary completion 2021-03-01 (estimated), completion 2021-05-01 (estimated), first posted 2020-12-28, last updated 2021-01-26 |
| Locations | 2 sites in Poland |
Related Papers Related Patents Related Grants Related Experts
All trials for Atrial Fibrillation; Stroke Prevention All trials of observational study
Prevention of thromboembolic complications is an important part in the management of patients with atrial fibrillation (AF). European and American guidelines recommend the use of non-vitamin K antagonist oral anticoagulants (NOACs) over therapy with vitamin K antagonists (VKA) in most AF patients. The number of patients treated with NOACs has increased significantly during the last few years. In the primary randomized controlled trials leading to their approval, compared to warfarin, NOACs were shown to be either noninferior or superior for stroke prevention in AF, with similar or reduced rates of bleeding, especially intracranial haemorrhage.
The aim of this study was to assess the frequency of oral anticoagulants using, espescially apixaban, dabigatran, and rivaroxaban, and the predictors of their prescription in a group of hospitalised patients with AF.
Sex: All, ages: 18 Years to any, accepts healthy volunteers
Inclusion Criteria: \- non-valvular atrial fibrillation Exclusion Criteria: * valvular atrial fibrillation * death during hospitalization
| Facility | City | Country | Status |
|---|---|---|---|
| 1st Clinic of Cardiology and Electotherapy | Kielce, Grunwaldzka 45 | Poland | Recruiting |
| Iwona Gorczyca | Kielce | Poland | Recruiting |